Ken Fisher
ARRY

Ken Fisher’s Array Biopharma Inc ARRY Stock Holding History

Ken Fisher’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-105,726
Closed -$4.9M – 889
2019
Q2 		$4.9M Buy
105,726
+15,219
+17% +$427K 0.01% 436
2019
Q1 		$2.21M Buy
90,507
+2,251
+3% +$46.9K ﹤0.01% 513
2018
Q4 		$1.26M Hold
88,256
– – ﹤0.01% 575
2018
Q3 		$1.34M Sell
88,256
-32,320
-27% -$495K ﹤0.01% 562
2018
Q2 		$2.02M Sell
120,576
-37,647
-24% -$599K ﹤0.01% 532
2018
Q1 		$2.58M Sell
158,223
-3,210
-2% -$51.4K ﹤0.01% 504
2017
Q4 		$2.07M Buy
161,433
+27,253
+20% +$310K ﹤0.01% 516
2017
Q3 		$1.65M Hold
134,180
– – ﹤0.01% 522
2017
Q2 		$1.12M Buy
134,180
+56,166
+72% +$459K ﹤0.01% 526
2017
Q1 		$697K Buy
78,014
+12,321
+19% +$131K ﹤0.01% 536
2016
Q4 		$577K Sell
65,693
-70,202
-52% -$517K ﹤0.01% 552
2016
Q3 		$917K Buy
135,895
+200
+0.1% +$774 ﹤0.01% 520
2016
Q2 		$507K Hold
135,695
– – ﹤0.01% 559
2016
Q1 		$430K Hold
135,695
– – ﹤0.01% 576
2015
Q4 		$573K Hold
135,695
– – ﹤0.01% 556
2015
Q3 		$619K Buy
+135,695
New +$805K ﹤0.01% 534

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Ken Fisher's ARRY Position: Q3 2019 in Review

Ken Fisher sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 105,726 shares — an estimated $4.9M sold.

Ken Fisher first reported a position in ARRY in Q3 2015 and held it in 16 quarters. The position peaked at $4.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Ken Fisher reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Ken Fisher sold 105,726 Array Biopharma Inc shares in Q3 2019, an estimated $4.9M.
  • Ken Fisher first reported a position in Array Biopharma Inc in Q3 2015 and held it in 16 quarters.
  • Ken Fisher's Array Biopharma Inc position peaked at $4.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Fisher Asset Management's 13F filing for Q3 2019, filed 29 Oct 2019.